ORYZON GENOMICS S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.98 EUR | -2.46% |
|
+3.12% | +4.87% |
Chart calendar Oryzon Genomics S.A.
3ab00272b8f7c.zAGRTSFBWZSf_8RJeNKecdsKUXh-6-5cI5R1dE73YI4._3n2CxcWPPfJsvMiAv_2Q7hMYD09h5QKbOQNIgGWWcGfNqYjahAu_ta4rw~816a2985e261672d712e85c010fc297c
Upcoming events on Oryzon Genomics S.A.
Past events on Oryzon Genomics S.A.
| 2024-04-21 | Swiss Biotech Day |
| 2024-04-15 | Van Lanschot Kempen Life Sciences Conference |
| 2024-03-17 | BioEurope Spring Conference |
| 2024-02-27 | European Life Sciences CEO Forum |
| 2024-02-26 02:28 pm | Q4 2023 Earnings Release |
| 2024-02-13 | Bio Neuroscience Conference |
| 2024-02-06 | Keystone Symposia Epigenetic Mechanisms and Cancer Treatment conference |
| 2024-01-29 | Invest Securities Biomed Forum |
| 2024-01-25 10:00 am | Investor Meeting - Key Opinion Leader |
| 2024-01-09 05:30 pm | Biotech Showcase |
| 2024-01-07 08:30 pm | PORTICO Study Phase IIb Results Call |
| 2024-01-07 | LifeSci Partners Corporate Access Event |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2024-01-07 04:00 pm | Sachs Neuroscience Innovation Forum |
| 2023-11-13 | BIO Europe Conference |
| 2023-11-12 | LSX Investival Showcase |
| 2023-11-05 | Bio-Europe Conference |
| 2023-10-27 12:12 pm | Q3 2023 Earnings Release |
| 2023-10-19 | European Society for Medical Oncology Congress |
| 2023-10-12 10:00 am | Roth Healtcare Opportunities Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 6,78 7,03 -3.6% | 0,00 3,26 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 3,60 - | 0,00 0,00 - |
|
EBITDA Million EUR | Released Forecast Spread | -2,77 -4,68 40.79% | -3,68 -4,27 13.78% | -4,14 -4,09 -1.31% | -6,87 -5,80 -18.38% | -5,32 -4,97 -7.22% | 0,00 -5,25 - |
|
EBIT Million EUR | Released Forecast Spread | -10,2 -10,5 2.81% | -3,97 -4,44 10.6% | -4,34 -4,23 -2.69% | -17,6 -17,8 1.13% | -21,4 -13,4 -59.54% | -19,2 -12,1 -59.27% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -3,71 -6,35 41.53% | -4,58 -5,13 10.84% | -4,34 -5,18 16.31% | -6,94 -7,36 5.67% | -5,49 -6,08 9.63% | -4,63 -6,12 24.26% |
|
Net income Million EUR | Released Forecast Spread | -1,18 -4,15 71.63% | -3,81 -3,24 -17.63% | -3,43 -3,86 11.06% | -4,64 -5,01 7.36% | -4,23 -4,01 -5.54% | -3,42 -3,56 4.05% |
|
EPS EUR | Released Forecast Spread | -0,03 -0,11 72.64% | -0,09 -0,10 7.94% | -0,07 -0,08 21.6% | -0,09 -0,09 6.03% | -0,08 -0,08 1.72% | -0,06 -0,06 -0.56% |
| Announcement Date | 15/02/19 | 24/02/20 | 23/02/21 | 07/02/22 | 17/02/23 | 26/02/24 |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2021 Q2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million EUR | Released Forecast Spread | -1,62 -2,20 26.21% | -7,69 -2,10 -266.11% | -3,32 -2,40 -38.24% | -5,14 -4,71 -9.23% | -14,2 -2,60 -445.56% | -1,76 -3,46 49.2% | -3,36 -3,90 13.77% | -5,00 -6,02 17% | -5,89 -5,26 -12.11% | -4,60 | -4,84 -5,61 13.67% | -2,47 | -4,24 -5,34 20.49% | -4,55 | -4,92 | -5,20 | -5,51 | ||||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -1,94 -2,60 25.21% | -2,16 -2,10 -2.62% | -1,57 -2,36 33.25% | -3,32 -2,90 -14.4% | -1,54 -1,50 -2.75% | -2,12 -2,30 7.97% | -3,50 -3,40 -2.85% | -1,66 -2,49 33.31% | -1,75 -3,14 44.25% | -3,44 -4,10 16.18% | -0,69 -2,90 76.06% | -1,49 -2,62 43.12% | -5,00 | -1,61 -3,17 49% | -1,18 -1,99 40.78% | -3,27 | -0,78 -2,34 66.66% | -2,43 | -1,70 | -1,80 | -3,20 | -1,90 | -3,20 |
|
Net income Million EUR | Released Forecast Spread | -1,97 -0,90 -119.06% | -1,31 -2,10 37.76% | 0,80 -2,27 135.16% | -1,02 -2,90 64.87% | -1,57 -1,42 -11.05% | -2,06 -2,34 11.79% | -3,59 -3,40 -5.45% | -1,72 -2,54 32.02% | 0,34 -1,87 118.18% | -1,30 -4,10 68.33% | -0,63 -2,94 78.71% | -2,30 -2,61 11.95% | -4,90 | -1,61 -2,94 45.01% | 1,04 -1,48 170.31% | -0,57 | -1,06 -2,40 55.76% | -1,64 | -1,79 | -1,88 | -3,20 | -2,01 | -1,20 |
|
EPS EUR | Released Forecast Spread | -0,05 0,00 - | -0,03 0,00 - | 0,02 -0,04 140.05% | -0,02 -0,10 83.18% | -0,03 -0,03 -2.72% | -0,03 -0,04 20.55% | -0,07 -0,10 29.99% | -0,03 -0,05 37.23% | 0,01 -0,04 124.86% | -0,03 -0,10 70.55% | -0,01 -0,05 79.74% | -0,05 -0,05 1.28% | -0,10 | -0,03 -0,06 50.31% | 0,02 -0,03 165.67% | -0,01 | -0,02 -0,04 55.05% | -0,03 | -0,03 | -0,03 | -0,10 | -0,03 | 0,00 |
| Announcement Date | 24/02/20 | 22/07/20 | 29/07/21 | 29/07/21 | 28/10/21 | 07/02/22 | 07/02/22 | 05/05/22 | 22/07/22 | 22/07/22 | 02/11/22 | 17/02/23 | - | 10/05/23 | 24/07/23 | 24/07/23 | 27/10/23 | - | - | - | - | - | - |
More events
Past sector events for Oryzon Genomics S.A.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ORY Stock
- Calendar Oryzon Genomics S.A.
